Health Canada said it was investigating the possible presence of a carcinogen in some ranitidine drugs available by prescription and over-the-counter.

This entry was posted on Saturday, October 19th, 2019 at 7:29 am and is filed under Finance/ Money. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.